AC
ADAR1 Capital Management, LLC disclosed a 8.7% stake in FULC
ADAR1 Capital Management, LLC reported owning 8.7% of Fulcrum Therapeutics, Inc. (FULC) (6,648,027 shares) in a Schedule 13G filed Nov 17, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.
- Disclosed
- Nov 17, 2026
- Source
- Schedule 13G